What is the dosage of Paclitaxel (generic name) for a patient with a body surface area (BSA) of 2 square meters (m2) when administering 175 milligrams per square meter (mg/m2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, if the body surface area (BSA) is 2 m² and the prescribed dose of paclitaxel is 175 mg/m², then the total dose would be 350 mg. This is calculated by multiplying the dose per square meter by the total BSA (175 mg/m² × 2 m² = 350 mg) 1. Paclitaxel dosing is typically based on BSA to account for differences in patient size, which affects drug distribution and metabolism. This approach helps optimize efficacy while minimizing toxicity.

Key Considerations

  • The dosing of paclitaxel is supported by guidelines that emphasize the importance of calculating the dose based on the patient's BSA to ensure optimal treatment outcomes 1.
  • When preparing this medication, it's crucial to follow institutional protocols for dilution and administration, as paclitaxel requires specific infusion techniques and premedication to prevent hypersensitivity reactions.
  • Always double-check the BSA calculation and resulting dose before administration, as precision is critical with chemotherapeutic agents like paclitaxel.

Clinical Context

  • The calculation of paclitaxel dose based on BSA is a standard practice in oncology, reflecting the drug's pharmacokinetics and the need to balance efficacy with the risk of adverse effects 1.
  • Recent guidelines and studies continue to support the use of BSA-based dosing for paclitaxel, underscoring its importance in clinical practice 1.

From the FDA Drug Label

The results of this randomized study support the use of Paclitaxel Injection, USP at doses of 135 to 175 mg/m2, administered by a 3-hour intravenous infusion. To calculate the dosage of paclitaxel for a patient with a BSA of 2m2, we can use the formula: Dosage = Dose per m2 x BSA Given the dose per m2 is 175mg/m2 and the BSA is 2m2, Dosage = 175mg/m2 x 2m2 = 350mg So, the dosage of paclitaxel for this patient would be 350mg 2.

From the Research

Calculating Paclitaxel Dosage

To determine if the dosage of 350mg is correct for a patient with a body surface area (BSA) of 2m^2 and a prescribed dose of 175mg/m^2, we can calculate the total dose as follows:

  • BSA: 2m^2
  • Prescribed dose: 175mg/m^2
  • Total dose = BSA * Prescribed dose = 2m^2 * 175mg/m^2 = 350mg

Relevant Studies

The calculated dosage is consistent with the information provided in the studies, which discuss the use of paclitaxel in various cancer treatments 3, 4, 5, 6, 7.

  • The study by 4 mentions that a dose of 175mg/m^2 is being investigated for heavily pretreated patients with metastatic breast cancer.
  • However, none of the studies provide a direct calculation or confirmation of the dosage for a patient with a BSA of 2m^2.

Dosage Confirmation

Based on the calculation, the dosage of 350mg appears to be correct for a patient with a BSA of 2m^2 and a prescribed dose of 175mg/m^2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

nab-Paclitaxel dose and schedule in breast cancer.

Breast cancer research : BCR, 2015

Research

Current opinion on the pharmacogenomics of paclitaxel-induced toxicity.

Expert opinion on drug metabolism & toxicology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.